Clinical trial · Observational
Thoracic Tumours Register
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Observational, multicenter study in patients with lung cancer and other thoracic tumors. The GECP, in its commitment to improve the treatment and prognosis of patients with lung cancer and other thoracic tumors, has marked the individualization of treatment according to the expression of markers predictive of response to chemotherapeutic agents and molecular inhibitors of cell proliferation as one of its primary objectives. This could significantly improve the prognosis of patients with lung cancer, and will lead to a radical change in routine clinical practice. The aim of the register is to explore all data available of all patients treated because of thoracic tumours.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Thoracic Tumors | Thoracic Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (5)
- label
- Non-small cell lung cancer
- description
- patients treated for a non small cell lung cancer
- label
- Small cell lung cancer
- description
- patients treated for a small cell lung cancer
- label
- Mesotelioma
- description
- patients treated for a mesotelioma
- label
- timic cancer
- description
- patients treated for a timic cancer
- label
- carcinoid cancer
- description
- patients treated for a carcinoid cancer
Primary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Patients with thoracic disease, treated with an active treatment or not treated (only palliative care) Exclusion Criteria: * Patients with other type of tumours
References
Publications (2)
- DERIVEDProvencio M, Cobo M, Rodriguez-Abreu D, Carcereny E, Calvo V, Castro RL, Bernabe R, Bruno MF, Bosch-Barrera J, Barco ED, Medina K, Sanchez-Hernandez A, Suay G, Ortega AL, Vazquez S, Lazaro-Quintela M, Guirado M, Estival A, Blanco M, Cantero A, Massuti B. Biomarker landscape in advanced NSCLC: insights from a national prospective registry. Lung Cancer. 2025 Sep;207:108680. doi: 10.1016/j.lungcan.2025.108680. Epub 2025 Jul 28. PMID 40749260
- DERIVEDProvencio M, Cobo M, Rodriguez-Abreu D, Carcereny E, Cantero A, Calvo V, Lopez Castro R, Bernabe R, Bosch-Barrera J, Massuti B, Garcia Campelo R, Sanchez-Hernandez A, Laura Ortega A, Guirado M, Del Barco E, Camps C, Casal-Rubio J, Domine M, Angeles Sala M, Padilla A, Luis Gonzalez Larriba J, de Asis Aparisi F; Spanish Lung Cancer Group SLCG/GECP. Describing differences among populations of thoracic tumors patients under and over 80 years: Data analysis from the SLCG thoracic tumor registry. Lung Cancer. 2024 Apr;190:107513. doi: 10.1016/j.lungcan.2024.107513. Epub 2024 Feb 29. PMID 38432027